Polo-like kinase-1 (PLK-1) inhibitors as novel therapeutics in oral squamous cell carcinomaSubhanwita Sarkar(University of Calgary)Open MINDJuly 22, 201910.11575/prism/36763Cited by 0SaveCiteExport RISWatch citationsRelated PapersTargeting Oral Squamous Cell Carcinoma with Combined Polo-Like-Kinase-1 Inhibitors and γ-Radiation Therapy|Biomedicines|2024|4